Cover Image
市場調查報告書

神經痛:全球臨床實驗檢討

Neuralgia Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 172372
出版日期 內容資訊 英文 163 Pages
訂單完成後即時交付
價格
Back to Top
神經痛:全球臨床實驗檢討 Neuralgia Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月21日 內容資訊: 英文 163 Pages
簡介

本報告提供神經痛相關臨床研究最新趨勢分析,提供您疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7個國家)的臨床實驗數及實驗對象採用狀況,地區、Phase、階段別的進展,有潛力的贊助商,各企業研究機關的研究進展及有潛力藥劑的比較等資訊。

簡介

  • 神經痛
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:中樞神經系統臨床實驗數量中,神經痛臨床實驗數量所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統臨床實驗數量中,神經痛臨床實驗數量所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

神經痛治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • AstraZeneca PLC
    • NeurogesX, Inc.
    • Grunenthal GmbH
    • GlaxoSmithKline plc
    • GW Pharmaceuticals plc
    • Merck & Co., Inc.
    • Spinifex Pharmaceuticals Pty Limited
    • Endo International plc
    • Eli Lilly and Company
  • 有代表性的研究機關·醫院臨床實驗概要
    • University Hospital of Clermont-Ferrand
    • Lawson Health Research Institute
    • Stanford University
    • Rigshospitalet
    • Danish Pain Research Center
    • Leiden University Medical Center
    • Rambam Health Care Campus
    • University of Manitoba
    • University of California, San Francisco
    • U.S. Department of Veterans Affairs

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2253CTIDB

GlobalData's clinical trial report, "Neuralgia Global Clinical Trials Review, H2, 2014" provides data on the Neuralgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuralgia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuralgia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Neuralgia
  • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Neuralgia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Neuralgia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Neuralgia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Neuralgia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • NeurogesX, Inc.
      • Clinical Trial Overview of NeurogesX, Inc.
      • Grunenthal GmbH
      • Clinical Trial Overview of Grunenthal GmbH
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • GW Pharmaceuticals plc
      • Clinical Trial Overview of GW Pharmaceuticals plc
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Spinifex Pharmaceuticals Pty Limited
      • Clinical Trial Overview of Spinifex Pharmaceuticals Pty Limited
      • Endo International plc
      • Clinical Trial Overview of Endo International plc
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
    • Clinical Trial Overview of Top Institutes / Government
      • University Hospital of Clermont-Ferrand
      • Clinical Trial Overview of University Hospital of Clermont-Ferrand
      • Lawson Health Research Institute
      • Clinical Trial Overview of Lawson Health Research Institute
      • Stanford University
      • Clinical Trial Overview of Stanford University
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • Danish Pain Research Center
      • Clinical Trial Overview of Danish Pain Research Center
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Rambam Health Care Campus
      • Clinical Trial Overview of Rambam Health Care Campus
      • University of Manitoba
      • Clinical Trial Overview of University of Manitoba
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Neuralgia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Neuralgia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Neuralgia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Neuralgia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Neuralgia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Neuralgia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Neuralgia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Neuralgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Neuralgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Neuralgia to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Neuralgia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Neuralgia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Neuralgia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Neuralgia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Neuralgia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Neuralgia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Grunenthal GmbH, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spinifex Pharmaceuticals Pty Limited, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Clermont-Ferrand, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Pain Research Center, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Neuralgia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*

List of Figures

  • Neuralgia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Neuralgia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Neuralgia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Neuralgia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Neuralgia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Neuralgia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Neuralgia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Neuralgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Neuralgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Neuralgia to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Neuralgia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Neuralgia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Neuralgia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Neuralgia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Neuralgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top